Record Information
Version1.0
Creation Date2009-06-23 18:10:09 UTC
Update Date2026-05-14 18:11:41 UTC
Accession NumberCHEM001599
Identification
Common NamePermethrin
ClassSmall Molecule
DescriptionPermethrin is only found in individuals that have used or taken this drug. It is a pyrethroid insecticide commonly used in the treatment of lice infestations and scabies. It is a yellow to light orange-brown, low melt-ing solid or viscous liquid.Permethrin acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and paralysis of the pests are the consequences of this disturbance.
Contaminant Sources
  • Clean Air Act Chemicals
  • EPA Endocrine Screening
  • HMDB Contaminants - Urine
  • HPV EPA Chemicals
  • IARC Carcinogens Group 3
  • My Exposome Chemicals
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Drug
  • Ester
  • Ether
  • Household Toxin
  • Metabolite
  • Organic Compound
  • Organochloride
  • Pesticide
  • Pyrethroid
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylateChEBI
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl esterChEBI
ElimiteKegg
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acidGenerator
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylate, (3-phenoxyphenyl) methyl esterGenerator
(m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylateMeSH
3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, esterMeSH
3-Phenoxybenzyl-cis,trans-(1Rs)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylateMeSH
AmbushMeSH
Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl esterMeSH
NRDC 143MeSH
NRDC 147MeSH
NRDC-143MeSH
NRDC-147MeSH
NRDC143MeSH
NRDC147MeSH
NittiforMeSH
Permethrin, (1R-cis)-isomerMeSH
Permethrin, (1R-trans)-isomerMeSH
Permethrin, (1S-cis)-isomerMeSH
Permethrin, (1S-trans)-isomerMeSH
Permethrin, (cis)-isomerMeSH
Permethrin, (cis-(+-))-isomerMeSH
Permethrin, (trans)-isomerMeSH
Permethrin, (trans-(+-))-isomerMeSH
Permethrin, trans-(1Rs)-isomerMeSH
cis PermethrinMeSH
cis-(1Rs)-PermethrinMeSH
cis-PermethrinMeSH
Permethrin, cis-(1Rs)-isomerMeSH
trans PermethrinMeSH
trans-(1Rs)-PermethrinMeSH
trans-PermethrinMeSH
Chemical FormulaC21H20Cl2O3
Average Molecular Mass391.288 g/mol
Monoisotopic Mass390.079 g/mol
CAS Registry Number52645-53-1
IUPAC Name(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
Traditional Namepermethrin
SMILESCC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC(OC2=CC=CC=C2)=CC=C1
InChI IdentifierInChI=1S/C21H20Cl2O3/c1-21(2)17(12-18(22)23)19(21)20(24)25-13-14-7-6-10-16(11-14)26-15-8-4-3-5-9-15/h3-12,17,19H,13H2,1-2H3
InChI KeyRLLPVAHGXHCWKJ-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as pyrethroids. These are organic compounds similar to the pyrethrins. Some pyrethroids containing a chrysanthemic acid esterified with a cyclopentenone (pyrethrins), or with a phenoxybenzyl group.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassFatty acid esters
Direct ParentPyrethroids
Alternative Parents
Substituents
  • Pyrethroid skeleton
  • Diphenylether
  • Diaryl ether
  • Benzyloxycarbonyl
  • Phenoxy compound
  • Phenol ether
  • Monocyclic benzene moiety
  • Cyclopropanecarboxylic acid or derivatives
  • Benzenoid
  • Carboxylic acid ester
  • Ketene acetal or derivatives
  • Carboxylic acid derivative
  • Chloroalkene
  • Haloalkene
  • Ether
  • Vinyl halide
  • Monocarboxylic acid or derivatives
  • Vinyl chloride
  • Organic oxide
  • Carbonyl group
  • Hydrocarbon derivative
  • Organohalogen compound
  • Organochloride
  • Organooxygen compound
  • Organic oxygen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
Applications
Biological Roles
Chemical RolesNot Available
Physical Properties
StateSolid
Appearance Colourless crystals (11).
Experimental Properties
PropertyValue
Melting Point34°C
Boiling Point220°C at 5.00E-02 mm Hg
Solubility0.006 mg/L (at 20°C)
Predicted Properties
PropertyValueSource
Water Solubility6.9e-05 g/LALOGPS
logP6.24ALOGPS
logP5.7ChemAxon
logS-6.8ALOGPS
pKa (Strongest Basic)-3.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area35.53 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity114.28 m³·mol⁻¹ChemAxon
Polarizability39.43 ųChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-3900000000-469dc103f8f391a6bb7fSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0002-1900000000-956860faa94e3dea2ee2Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0002-1900000000-ce2901f0a3049806d95fSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0002-1900000000-b5846ca870454df7f44fSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0002-0900000000-474995c2ccb155f0975cSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0002-1900000000-261c3708f1e50c4a8418Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-006t-2900000000-4915b2e2cee108c117a2Spectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-0002-0900000000-a73154cdccdc124955c0Spectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Positivesplash10-0002-1900000000-2f9800db80661116530aSpectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-0002-1900000000-bf65bfc29edf7e8f72d6Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-0002-1900000000-91cb4c87ae286d88f203Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Positivesplash10-0002-1900000000-2546d86434c241ad989eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0006-0519000000-0f6eb9a687fe3c0d66c4Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0006-1923000000-a400c6833ac566d7a622Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-052e-2900000000-7758be41aece58f5d5d1Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-000i-0109000000-fdac422c546f05b83cebSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-000i-1709000000-f755eb7d0bee859d0bb8Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0006-9500000000-97e9860533a91746241dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0536-0429000000-98939aa3532b9312d6acSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-001i-2923000000-0cd57653df5af5d7ac42Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-001l-8911000000-9f85adb3775c89af21a5Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-000i-0119000000-eda907ff628cd2b35844Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-03ki-1902000000-84bc834f9310543ce7d7Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0006-9211000000-bcaffb823cfb3efededaSpectrum
Toxicity Profile
Route of ExposureInhalation (10) ; oral (10) ; dermal (10) ; eye contact (10). Poorly absorbed through the skin.
Mechanism of ToxicityPyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in the immediate vicinity of the sodium channel, thus modifying the channel kinetics. This blocks the closing of the sodium gates in the nerves, and thus prolongs the return of the membrane potential to its resting state. The repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential produces effects quite similar to those produced by DDT, leading to hyperactivity of the nervous system which can result in paralysis and/or death. Other mechanisms of action of pyrethroids include antagonism of gamma-aminobutyric acid (GABA)-mediated inhibition, modulation of nicotinic cholinergic transmission, enhancement of noradrenaline release, and actions on calcium ions. (12, 10)
MetabolismThe proposed metabolic pathway for cis- and trans-permethrin are as follows. The five principle sites of metabolic attack in both permethrin isomers is ester cleavage, oxidation at the trans- and cis-methyl of the geminal dimethyl group of the acid moiety, and oxidation at 2'- and 4'- position of the phenoxy group. Conjugation of the resultant carboxylic acids, alcohols, and phenols with glucuronic acid, glycine, and sulfuric acid occurs to varying extent. cis-Permethrin is more stable then trans-permethrin, and the cis isomer yields four faecally excreted ester metabolites that results from hydroxylation at the 2'- or 4'-position of the phenoxy group or at the trans- or cis methyl group on the cyclopropane ring. The estercleaved metabolites are extensively excreted into the urine whereas the metabolites retaining an ester bond are found only in the feces. The major metabolite from the acid moiety of both isomers was Cl2CA in free (1-8%) and glucuronide (14-42%) forms. Other significant metabolites are trans-OH-Cl2CA (1-5%) and cis-OH-Cl2CA in the free (3-5%), lactone (0-4%) and glucuronide (1-2%) forms. On the other hand, the alcohol moiety released after cleavage of the ester bond of both isomers is converted mainly to the sulfate of 3-(4'-hydroxyphenoxy)benzoic acid (4'-OH-PBacid) (29-43% of the dose) and PBacid in the free (1-10%) and glucuronide (7-15%) forms. Other significant metabolites of the alcohol moiety are PBalc, PBacid-glycine and the sulfate of 3-(2'-hydroxyphenoxy) benzoic acid (2'-OH-PBacid). A study by Nakamura et al. proposed that permethrin was hydrolyzed by CES (carboxylesterase), then PBAlc formed was oxidized to PBAld, and further, PBAld was oxidized to PBAcid by the P450 system in rat liver microsomes. (5, 2) Route of Elimination: Permethrin is rapidly metabolized by ester hydrolysis to inactive metabolites which are excreted primarily in the urine.
Toxicity ValuesOral, rat LD50: 430 - 4000 mg/kg Skin, rabbit LD50: 2000 mg/kg LD50: 3 801 mg/kg (Oral, Rat) (10)
Lethal DoseNot Available
Carcinogenicity (IARC Classification)3, not classifiable as to its carcinogenicity to humans. (7)
Uses/SourcesFor the treatment of infestation with Sarcoptes scabiei (scabies). Pyrethroids are used as insecticides. (10)
Minimum Risk LevelIntermediate Oral: 0.2 mg/kg/day (Rat) (10)
Health EffectsAs for every type I pyrethroids , permethrin effects typically include rapid onset of aggressive behavior and increased sensitivity to external stimuli, followed by fine tremor, prostration with coarse whole body tremor, elevated body temperature, coma, and death. Paresthesia, severe corneal damage, hypotension and tachycardia, associated with anaphylaxis can also occur following permethrin poisoning. (10)
SymptomsFollowing oral exposure, severe fine tremor, marked reflex hyperexcitability, sympathetic activation can occur. Nausea, vomiting and abdominal pain commonly occur and develop following ingestion. Sudden bronchospasm, swelling of oral and laryngeal mucous membranes, and anaphylactoid reactions have been reported after inhalation. Hypersensitivity reactions characterized by pneumonitis, cough, dyspnea, wheezing, chest pain, and bronchospasm may occur too . Dermatitis is the main effect of a dermal exposure to permethrin. (13)
TreatmentFollowing oral exposure, the treatment is symptomatic and supportive and includes monitoring for the development of hypersensitivity reactions with respiratory distress. Provide adequate airway management when needed. Gastric decontamination is usually not required unless the pyrethrin product is combined with a hydrocarbon. Following inhalation exposure, move patient to fresh air. monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility. If the contamination occurs through dermal exposure, remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. Vitamin E topical application is highly effective in relieving parenthesis. (13)
Concentrations
Not Available
DrugBank IDDB04930
HMDB IDHMDB0250296
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkPermethrin
Chemspider ID36845
ChEBI ID34911
PubChem Compound ID40326
Kegg Compound IDC14388
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSLink
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=11082455
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=12419701
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=14617103
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=15599112
5. https://www.ncbi.nlm.nih.gov/pubmed/?term=15663293
6. https://www.ncbi.nlm.nih.gov/pubmed/?term=15966049
7. https://www.ncbi.nlm.nih.gov/pubmed/?term=16423402
8. https://www.ncbi.nlm.nih.gov/pubmed/?term=16481707
9. https://www.ncbi.nlm.nih.gov/pubmed/?term=16599165
10. https://www.ncbi.nlm.nih.gov/pubmed/?term=17140720
11. https://www.ncbi.nlm.nih.gov/pubmed/?term=17220085
12. https://www.ncbi.nlm.nih.gov/pubmed/?term=17451859
13. https://www.ncbi.nlm.nih.gov/pubmed/?term=17597311
14. https://www.ncbi.nlm.nih.gov/pubmed/?term=17980950
15. https://www.ncbi.nlm.nih.gov/pubmed/?term=18274958
16. https://www.ncbi.nlm.nih.gov/pubmed/?term=18570364
17. https://www.ncbi.nlm.nih.gov/pubmed/?term=18692543
18. https://www.ncbi.nlm.nih.gov/pubmed/?term=18723882
19. https://www.ncbi.nlm.nih.gov/pubmed/?term=19079720
20. https://www.ncbi.nlm.nih.gov/pubmed/?term=19090765
21. https://www.ncbi.nlm.nih.gov/pubmed/?term=19278716
22. https://www.ncbi.nlm.nih.gov/pubmed/?term=19343362
23. https://www.ncbi.nlm.nih.gov/pubmed/?term=19835699
24. https://www.ncbi.nlm.nih.gov/pubmed/?term=19962303
25. https://www.ncbi.nlm.nih.gov/pubmed/?term=20960224
26. https://www.ncbi.nlm.nih.gov/pubmed/?term=21069313
27. https://www.ncbi.nlm.nih.gov/pubmed/?term=21133424
28. https://www.ncbi.nlm.nih.gov/pubmed/?term=21235202
29. https://www.ncbi.nlm.nih.gov/pubmed/?term=21240732
30. https://www.ncbi.nlm.nih.gov/pubmed/?term=21251955
31. https://www.ncbi.nlm.nih.gov/pubmed/?term=21352824
32. https://www.ncbi.nlm.nih.gov/pubmed/?term=21485369
33. https://www.ncbi.nlm.nih.gov/pubmed/?term=21756140
34. https://www.ncbi.nlm.nih.gov/pubmed/?term=21809414
35. https://www.ncbi.nlm.nih.gov/pubmed/?term=21812972
36. https://www.ncbi.nlm.nih.gov/pubmed/?term=25042713